+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Self-injections Market Research Report by Type, Usage, Distribution Channel, Therapeutic Areas Application, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 259 Pages
  • October 2022
  • Region: Global
  • 360iResearch™
  • ID: 4985960
UP TO OFF until Dec 31st 2022
The Global Self-injections Market size was estimated at USD 41.75 billion in 2021, USD 46.73 billion in 2022, and is projected to grow at a CAGR of 12.79% to reach USD 86.00 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Self-injections to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market was studied across Auto-Injectors, Needle-free Injectors, Pen Injectors, and Wearable Injectors.
  • Based on Usage, the market was studied across Disposable and Reusable.
  • Based on Distribution Channel, the market was studied across Hospital Pharmacies, Online Pharmacies, and Private Clinics.
  • Based on Therapeutic Areas Application, the market was studied across Autoimmune Diseases, Emergency Drugs, and Hormone Replacement Therapies. The Autoimmune Diseases is further studied across AIDS, Allergies, Cancer, Irritable Bowel Disorders, Multiple Sclerosis, and Psoriasis. The Emergency Drugs is further studied across Anaphylactic Socks and Migraine. The Hormone Replacement Therapies is further studied across Beta-Interferon, Erythropoietin, Follicle Stimulating Hormone, Heparin, Insulin, Parathyroid Hormone, and Parkinson’s.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. The ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Self-injections market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Self-injections Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Self-injections Market, including AbbVie Inc., Antares Pharma, Inc., Baxter International, Inc., Becton, Dickinson and Company, Credence MedSystems, Inc., DALI Medical Devices, Eli Lilly and Company, Enable Injections, Inc., Gerresheimer AG, Insulet Corporation, Owen Mumford Limited, PenJet Corporation, Pfizer Inc., PharmaJet, Inc., Recipharm AB, SCHOTT AG, SHL Group, Terumo Corporation, West Pharmaceutical Services, Inc., Wilhelm Haselmeier GmbH & Co. KG, and Ypsomed Group.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Self-injections Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Self-injections Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Self-injections Market?
4. What is the competitive strategic window for opportunities in the Global Self-injections Market?
5. What are the technology trends and regulatory frameworks in the Global Self-injections Market?
6. What is the market share of the leading vendors in the Global Self-injections Market?
7. What modes and strategic moves are considered suitable for entering the Global Self-injections Market?
Frequently Asked Questions about the Global Self-injections Market

What is the estimated value of the Global Self-injections Market?

The Global Self-injections Market was estimated to be valued at $41.75 Billion in 2021.

What is the growth rate of the Global Self-injections Market?

The growth rate of the Global Self-injections Market is 12.7%, with an estimated value of $86 Billion by 2027.

What is the forecasted size of the Global Self-injections Market?

The Global Self-injections Market is estimated to be worth $86 Billion by 2027.

Who are the key companies in the Global Self-injections Market?

Key companies in the Global Self-injections Market include AbbVie Inc., Antares Pharma, Inc., Baxter International, Inc., Becton, Dickinson and Company, Credence MedSystems, Inc., DALI Medical Devices, Eli Lilly and Company, Enable Injections, Inc. and Insulet Corporation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid Prevalence of Chronic Diseases and Rheumatoid Arthritis
5.1.1.2. Technological Advancements in Self-Injection Devices
5.1.1.3. Availability in Drug Delivery for Biological and Biosimilar Drugs
5.1.2. Restraints
5.1.2.1. Strict Regulation for Patent Approval and Lack of Awareness
5.1.3. Opportunities
5.1.3.1. Development of Biologic Drugs to Treat Autoimmune Disease
5.1.3.2. Worldwide Increase in Diabetes and the Growing Pressure on Health Care Costs
5.1.4. Challenges
5.1.4.1. Growing Use of Alternative Delivery Methods
5.2. Cumulative Impact of COVID-19
6. Self-injections Market, by Type
6.1. Introduction
6.2. Auto-Injectors
6.3. Needle-free Injectors
6.4. Pen Injectors
6.5. Wearable Injectors
7. Self-injections Market, by Usage
7.1. Introduction
7.2. Disposable
7.3. Reusable
8. Self-injections Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Private Clinics
9. Self-injections Market, by Therapeutic Areas Application
9.1. Introduction
9.2. Autoimmune Diseases
9.3.1. AIDS
9.3.2. Allergies
9.3.3. Cancer
9.3.4. Irritable Bowel Disorders
9.3.5. Multiple Sclerosis
9.3.6. Psoriasis
9.3. Emergency Drugs
9.4.1. Anaphylactic Socks
9.4.2. Migraine
9.4. Hormone Replacement Therapies
9.5.1. Beta-Interferon
9.5.2. Erythropoietin
9.5.3. Follicle Stimulating Hormone
9.5.4. Heparin
9.5.5. Insulin
9.5.6. Parathyroid Hormone
9.5.7. Parkinson’s
10. Americas Self-injections Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Self-injections Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Self-injections Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis, By Key Player
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. AbbVie Inc.
14.1.1. Business Overview
14.1.2. Key Executives
14.1.3. Product & Services
14.2. Antares Pharma, Inc.
14.2.1. Business Overview
14.2.2. Key Executives
14.2.3. Product & Services
14.3. Baxter International, Inc.
14.3.1. Business Overview
14.3.2. Key Executives
14.3.3. Product & Services
14.4. Becton, Dickinson and Company
14.4.1. Business Overview
14.4.2. Key Executives
14.4.3. Product & Services
14.5. Credence MedSystems, Inc.
14.5.1. Business Overview
14.5.2. Key Executives
14.5.3. Product & Services
14.6. DALI Medical Devices
14.6.1. Business Overview
14.6.2. Key Executives
14.6.3. Product & Services
14.7. Eli Lilly and Company
14.7.1. Business Overview
14.7.2. Key Executives
14.7.3. Product & Services
14.8. Enable Injections, Inc.
14.8.1. Business Overview
14.8.2. Key Executives
14.8.3. Product & Services
14.9. Gerresheimer AG
14.9.1. Business Overview
14.9.2. Key Executives
14.9.3. Product & Services
14.10. Insulet Corporation
14.10.1. Business Overview
14.10.2. Key Executives
14.10.3. Product & Services
14.11. Owen Mumford Limited
14.11.1. Business Overview
14.11.2. Key Executives
14.11.3. Product & Services
14.12. PenJet Corporation
14.12.1. Business Overview
14.12.2. Key Executives
14.12.3. Product & Services
14.13. Pfizer Inc.
14.13.1. Business Overview
14.13.2. Key Executives
14.13.3. Product & Services
14.14. PharmaJet, Inc.
14.14.1. Business Overview
14.14.2. Key Executives
14.14.3. Product & Services
14.15. Recipharm AB
14.15.1. Business Overview
14.15.2. Key Executives
14.15.3. Product & Services
14.16. SCHOTT AG
14.16.1. Business Overview
14.16.2. Key Executives
14.16.3. Product & Services
14.17. SHL Group
14.17.1. Business Overview
14.17.2. Key Executives
14.17.3. Product & Services
14.18. Terumo Corporation
14.18.1. Business Overview
14.18.2. Key Executives
14.18.3. Product & Services
14.19. West Pharmaceutical Services, Inc.
14.19.1. Business Overview
14.19.2. Key Executives
14.19.3. Product & Services
14.20. Wilhelm Haselmeier GmbH & Co. KG
14.20.1. Business Overview
14.20.2. Key Executives
14.20.3. Product & Services
14.21. Ypsomed Group
14.21.1. Business Overview
14.21.2. Key Executives
14.21.3. Product & Services
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL SELF-INJECTIONS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL SELF-INJECTIONS MARKET SIZE, 2021 VS 2027
FIGURE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. GLOBAL SELF-INJECTIONS MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2027
FIGURE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL SELF-INJECTIONS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 10. GLOBAL SELF-INJECTIONS MARKET DYNAMICS
FIGURE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
FIGURE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL SELF-INJECTIONS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2027
FIGURE 14. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, 2018-2027 (USD MILLION)
FIGURE 15. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, 2018-2027 (USD MILLION)
FIGURE 17. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, 2018-2027 (USD MILLION)
FIGURE 18. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2021 VS 2027 (%)
FIGURE 19. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL SELF-INJECTIONS MARKET COMPETITIVE STRATEGIC WINDOW, BY USAGE, 2027
FIGURE 21. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, 2018-2027 (USD MILLION)
FIGURE 22. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 24. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL SELF-INJECTIONS MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION CHANNEL, 2027
FIGURE 26. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 28. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2021 VS 2027 (%)
FIGURE 30. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL SELF-INJECTIONS MARKET COMPETITIVE STRATEGIC WINDOW, BY THERAPEUTIC AREAS APPLICATION, 2027
FIGURE 32. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2027 (USD MILLION)
FIGURE 33. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AIDS, 2018-2027 (USD MILLION)
FIGURE 34. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ALLERGIES, 2018-2027 (USD MILLION)
FIGURE 35. GLOBAL SELF-INJECTIONS MARKET SIZE, BY CANCER, 2018-2027 (USD MILLION)
FIGURE 36. GLOBAL SELF-INJECTIONS MARKET SIZE, BY IRRITABLE BOWEL DISORDERS, 2018-2027 (USD MILLION)
FIGURE 37. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2027 (USD MILLION)
FIGURE 38. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PSORIASIS, 2018-2027 (USD MILLION)
FIGURE 39. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2027 (USD MILLION)
FIGURE 40. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ANAPHYLACTIC SOCKS, 2018-2027 (USD MILLION)
FIGURE 41. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MIGRAINE, 2018-2027 (USD MILLION)
FIGURE 42. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2027 (USD MILLION)
FIGURE 43. GLOBAL SELF-INJECTIONS MARKET SIZE, BY BETA-INTERFERON, 2018-2027 (USD MILLION)
FIGURE 44. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ERYTHROPOIETIN, 2018-2027 (USD MILLION)
FIGURE 45. GLOBAL SELF-INJECTIONS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, 2018-2027 (USD MILLION)
FIGURE 46. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HEPARIN, 2018-2027 (USD MILLION)
FIGURE 47. GLOBAL SELF-INJECTIONS MARKET SIZE, BY INSULIN, 2018-2027 (USD MILLION)
FIGURE 48. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARATHYROID HORMONE, 2018-2027 (USD MILLION)
FIGURE 49. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARKINSON’S, 2018-2027 (USD MILLION)
FIGURE 50. AMERICAS SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 51. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 52. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 53. AMERICAS SELF-INJECTIONS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 54. ARGENTINA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 55. BRAZIL SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 56. CANADA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 57. MEXICO SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 58. UNITED STATES SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 59. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 60. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 61. UNITED STATES SELF-INJECTIONS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 62. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 64. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 65. ASIA-PACIFIC SELF-INJECTIONS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 66. AUSTRALIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. CHINA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. INDIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. INDONESIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. JAPAN SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. MALAYSIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. PHILIPPINES SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. SINGAPORE SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. TAIWAN SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. THAILAND SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. VIETNAM SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 80. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 81. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2027
FIGURE 82. DENMARK SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. EGYPT SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. FINLAND SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. FRANCE SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. GERMANY SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. ISRAEL SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 88. ITALY SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 89. NETHERLANDS SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 90. NIGERIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 91. NORWAY SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 92. POLAND SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 93. QATAR SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 94. RUSSIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 95. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 96. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 97. SPAIN SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 98. SWEDEN SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 99. SWITZERLAND SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 100. TURKEY SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 101. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 102. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 103. GLOBAL SELF-INJECTIONS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 104. GLOBAL SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 105. GLOBAL SELF-INJECTIONS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. GLOBAL SELF-INJECTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, 2018-2027 (USD MILLION)
TABLE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, 2018-2027 (USD MILLION)
TABLE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2027 (USD MILLION)
TABLE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2027 (USD MILLION)
TABLE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2027 (USD MILLION)
TABLE 16. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, 2018-2027 (USD MILLION)
TABLE 17. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2027 (USD MILLION)
TABLE 18. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 20. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, 2018-2027 (USD MILLION)
TABLE 21. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2027 (USD MILLION)
TABLE 22. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2027 (USD MILLION)
TABLE 23. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2027 (USD MILLION)
TABLE 26. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 27. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2027 (USD MILLION)
TABLE 28. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 30. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2027 (USD MILLION)
TABLE 31. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 32. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 33. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 36. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 37. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2027 (USD MILLION)
TABLE 38. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 39. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AIDS, 2018-2027 (USD MILLION)
TABLE 41. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AIDS, BY REGION, 2018-2027 (USD MILLION)
TABLE 42. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AIDS, BY REGION, 2018-2027 (USD MILLION)
TABLE 43. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ALLERGIES, 2018-2027 (USD MILLION)
TABLE 44. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 46. GLOBAL SELF-INJECTIONS MARKET SIZE, BY CANCER, 2018-2027 (USD MILLION)
TABLE 47. GLOBAL SELF-INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD MILLION)
TABLE 48. GLOBAL SELF-INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD MILLION)
TABLE 49. GLOBAL SELF-INJECTIONS MARKET SIZE, BY IRRITABLE BOWEL DISORDERS, 2018-2027 (USD MILLION)
TABLE 50. GLOBAL SELF-INJECTIONS MARKET SIZE, BY IRRITABLE BOWEL DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 51. GLOBAL SELF-INJECTIONS MARKET SIZE, BY IRRITABLE BOWEL DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 52. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2018-2027 (USD MILLION)
TABLE 53. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 54. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 55. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PSORIASIS, 2018-2027 (USD MILLION)
TABLE 56. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 57. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2027 (USD MILLION)
TABLE 58. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2027 (USD MILLION)
TABLE 59. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 60. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 61. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ANAPHYLACTIC SOCKS, 2018-2027 (USD MILLION)
TABLE 62. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ANAPHYLACTIC SOCKS, BY REGION, 2018-2027 (USD MILLION)
TABLE 63. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ANAPHYLACTIC SOCKS, BY REGION, 2018-2027 (USD MILLION)
TABLE 64. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MIGRAINE, 2018-2027 (USD MILLION)
TABLE 65. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 66. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2027 (USD MILLION)
TABLE 67. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2027 (USD MILLION)
TABLE 68. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 69. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, BY REGION, 2018-2027 (USD MILLION)
TABLE 70. GLOBAL SELF-INJECTIONS MARKET SIZE, BY BETA-INTERFERON, 2018-2027 (USD MILLION)
TABLE 71. GLOBAL SELF-INJECTIONS MARKET SIZE, BY BETA-INTERFERON, BY REGION, 2018-2027 (USD MILLION)
TABLE 72. GLOBAL SELF-INJECTIONS MARKET SIZE, BY BETA-INTERFERON, BY REGION, 2018-2027 (USD MILLION)
TABLE 73. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ERYTHROPOIETIN, 2018-2027 (USD MILLION)
TABLE 74. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 75. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 76. GLOBAL SELF-INJECTIONS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, 2018-2027 (USD MILLION)
TABLE 77. GLOBAL SELF-INJECTIONS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2027 (USD MILLION)
TABLE 78. GLOBAL SELF-INJECTIONS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2027 (USD MILLION)
TABLE 79. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HEPARIN, 2018-2027 (USD MILLION)
TABLE 80. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HEPARIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 81. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HEPARIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 82. GLOBAL SELF-INJECTIONS MARKET SIZE, BY INSULIN, 2018-2027 (USD MILLION)
TABLE 83. GLOBAL SELF-INJECTIONS MARKET SIZE, BY INSULIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 84. GLOBAL SELF-INJECTIONS MARKET SIZE, BY INSULIN, BY REGION, 2018-2027 (USD MILLION)
TABLE 85. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARATHYROID HORMONE, 2018-2027 (USD MILLION)
TABLE 86. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARATHYROID HORMONE, BY REGION, 2018-2027 (USD MILLION)
TABLE 87. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARATHYROID HORMONE, BY REGION, 2018-2027 (USD MILLION)
TABLE 88. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARKINSON’S, 2018-2027 (USD MILLION)
TABLE 89. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARKINSON’S, BY REGION, 2018-2027 (USD MILLION)
TABLE 90. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARKINSON’S, BY REGION, 2018-2027 (USD MILLION)
TABLE 91. AMERICAS SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 92. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 93. AMERICAS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 94. AMERICAS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 95. AMERICAS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 96. AMERICAS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 97. ARGENTINA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 98. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 99. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 100. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 101. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 102. BRAZIL SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 103. BRAZIL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 104. BRAZIL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 105. BRAZIL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 106. BRAZIL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 107. CANADA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 108. CANADA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 109. CANADA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 110. CANADA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 111. CANADA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 112. MEXICO SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 113. MEXICO SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 114. MEXICO SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 115. MEXICO SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 116. MEXICO SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 117. UNITED STATES SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 118. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 119. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 120. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 121. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 122. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 123. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 124. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 125. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 126. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 127. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 128. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 129. AUSTRALIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 130. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 131. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 132. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 133. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 134. CHINA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 135. CHINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 136. CHINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 137. CHINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 138. CHINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 139. INDIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 140. INDIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 141. INDIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 142. INDIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 143. INDIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 144. INDONESIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 145. INDONESIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 146. INDONESIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 147. INDONESIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 148. INDONESIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 149. JAPAN SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 150. JAPAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 151. JAPAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 152. JAPAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 153. JAPAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 154. MALAYSIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 155. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 156. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 157. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 158. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 159. PHILIPPINES SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 160. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 161. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 162. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 163. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 164. SINGAPORE SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 165. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 166. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 167. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 168. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 169. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 170. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 171. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 172. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 173. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 174. TAIWAN SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 175. TAIWAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 176. TAIWAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 177. TAIWAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 178. TAIWAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 179. THAILAND SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 180. THAILAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 181. THAILAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 182. THAILAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 183. THAILAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 184. VIETNAM SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 185. VIETNAM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 186. VIETNAM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 187. VIETNAM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 188. VIETNAM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 195. DENMARK SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 196. DENMARK SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 197. DENMARK SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 198. DENMARK SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 199. DENMARK SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 200. EGYPT SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 201. EGYPT SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 202. EGYPT SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 203. EGYPT SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 204. EGYPT SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 205. FINLAND SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 206. FINLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 207. FINLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 208. FINLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 209. FINLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 210. FRANCE SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 211. FRANCE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 212. FRANCE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 213. FRANCE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 214. FRANCE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 215. GERMANY SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 216. GERMANY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 217. GERMANY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 218. GERMANY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 219. GERMANY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 220. ISRAEL SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 221. ISRAEL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 222. ISRAEL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 223. ISRAEL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 224. ISRAEL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 225. ITALY SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 226. ITALY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 227. ITALY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 228. ITALY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 229. ITALY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 230. NETHERLANDS SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 231. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 232. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 233. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 234. NETHERLANDS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 235. NIGERIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 236. NIGERIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 237. NIGERIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 238. NIGERIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 239. NIGERIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 240. NORWAY SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 241. NORWAY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 242. NORWAY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 243. NORWAY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 244. NORWAY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 245. POLAND SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 246. POLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 247. POLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 248. POLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 249. POLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 250. QATAR SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 251. QATAR SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 252. QATAR SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 253. QATAR SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 254. QATAR SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 255. RUSSIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 256. RUSSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 257. RUSSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 258. RUSSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 259. RUSSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 260. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 261. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 262. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 263. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 264. SAUDI ARABIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 265. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 266. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 267. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 268. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 269. SOUTH AFRICA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 270. SPAIN SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 271. SPAIN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 272. SPAIN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 273. SPAIN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 274. SPAIN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 275. SWEDEN SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 276. SWEDEN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 277. SWEDEN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 278. SWEDEN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 279. SWEDEN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 280. SWITZERLAND SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 281. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 282. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 283. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 284. SWITZERLAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 285. TURKEY SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 286. TURKEY SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 287. TURKEY SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 288. TURKEY SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 289. TURKEY SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 295. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 296. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2027 (USD MILLION)
TABLE 297. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2027 (USD MILLION)
TABLE 298. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 299. UNITED KINGDOM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2027 (USD MILLION)
TABLE 300. GLOBAL SELF-INJECTIONS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 301. GLOBAL SELF-INJECTIONS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 302. GLOBAL SELF-INJECTIONS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 303. GLOBAL SELF-INJECTIONS MARKET RANKING, BY KEY PLAYER, 2021
TABLE 304. GLOBAL SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 305. GLOBAL SELF-INJECTIONS MARKET MERGER & ACQUISITION
TABLE 306. GLOBAL SELF-INJECTIONS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 307. GLOBAL SELF-INJECTIONS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 308. GLOBAL SELF-INJECTIONS MARKET INVESTMENT & FUNDING
TABLE 309. GLOBAL SELF-INJECTIONS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 310. GLOBAL SELF-INJECTIONS MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Antares Pharma, Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Credence MedSystems, Inc.
  • DALI Medical Devices
  • Eli Lilly and Company
  • Enable Injections, Inc.
  • Gerresheimer AG
  • Insulet Corporation
  • Owen Mumford Limited
  • PenJet Corporation
  • Pfizer Inc.
  • PharmaJet, Inc.
  • Recipharm AB
  • SCHOTT AG
  • SHL Group
  • Terumo Corporation
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG
  • Ypsomed Group

Methodology

Loading
LOADING...